Add to My Stocks
$10 $0.03 (0.3%) GEMP stock closing price May 24, 2017 (Closing)
Prev Close* : $10.03
Market Cap:
Day Low: $9.98
52 Week Low: $7.25
Open: $9.98
Volume: 40936
Day High: $10.45
52 Week High: $13.98

Latest Stock Market News

Latest Articles

GEMP Stockcharts

View GEMP PE ratio, PS ratio stocks charts and compare with peers.
GEMP Chart
Note: Compare GEMPHIRE THERAP stock price history with the index and industry peers.

GEMP Industry Peers

Company Price Change (%)
Cidara Therapeutics (CDTX)6.70.05 (0.75%)
Proqr Therapeutics (PRQR)4.980.02 (0.4%)
Mannkind (MNKD)1.280.02 (1.54%)
Proteostasis (PTI)3.910.03 (0.77%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Puma Biotech (PBYI)74.9517.15 (29.67%)
Inovio Pharma (INO)8.681.55 (21.74%)
AMAG Pharma (AMAG)19.251.15 (6.35%)
Advaxis (ADXS)9.160.48 (5.53%)
Sorrento Therapeutics (SRNE)1.650.08 (5.08%)
MediciNova (MNOV)6.040.28 (4.86%)
Sinovac Biotech (SVA)4.880.22 (4.72%)
Top gainers from Medical-Biomed-Genetics industry
* As of May 24, 2017
CompanyPriceChange (%)
Alnylam Pharma (ALNY)69.974.9 (6.54%)
BioDelivery Sciences (BDSI)2.20.1 (4.35%)
Uniquire (QURE)5.660.21 (3.58%)
Alexion Pharma (ALXN)101.083.56 (3.4%)
Intra-Cellular Therapies (ITCI)10.260.34 (3.21%)
ALBIREO PHARMA (ALBO)21.210.66 (3.02%)
Alder BioPharma (ALDR)16.90.5 (2.87%)
Top losers from Medical-Biomed-Genetics industry
* As of May 24, 2017

GEMPHIRE THERAP Stock News - Partner Headlines

GEMPHIRE THERAP Financial Statements

income statement201620152014
Net Sales Or Revenues---
Net Income-14.58M-9.02M-0.32M
Total Operating Expense14.69M8.06M0.26M
view GEMPHIRE THERAP income statement
balance sheet201620152014
Total Assets24.75M4.5M0.34M
Total Liabilities4.12M8.92M0.87M
Shareholders Equity20.63M-4.42M-0.53M
view GEMPHIRE THERAP balance sheet
cash flow statement201620152014
Net Increase (Decrease) In Assets Liabilities1.91M1.44M0.01M
Net Cash From (Used By) Operating Activities-11.04M-5.43M-0.19M
Increase (Decrease) In Prop Plant And Equipment---
view GEMPHIRE THERAP cashflow statement

GEMPHIRE THERAP Stock Message Board

GEMPHIRE THERAP stock lost -0.3 %, and the last close price as of 23 May, 2017 is 10.03 for GEMP stock. Stock price or share price can be used to find the total market value of a company. GEMPHIRE THERAP market cap stands at 106.64M as of 23 May, 2017. GEMPHIRE THERAP valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that GEMPHIRE THERAP is worth a lot, it will most likely be reflected in an inflated GEMPHIRE THERAP stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume of shares traded stood at 34455 on the last trading day, as is evident from GEMPHIRE THERAP stock chart, and GEMP stock quote data. The board of directors decide what percentage of a company's earnings will be paid out as dividends. GEMPHIRE THERAP stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.